Pharmacokinetics and tolerability of posaconazole oral suspension in children with neutropenia or expected neutropenia

Trial Profile

Pharmacokinetics and tolerability of posaconazole oral suspension in children with neutropenia or expected neutropenia

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Nov 2013

At a glance

  • Drugs Posaconazole (Primary)
  • Indications Aspergillosis; Candidiasis; Chagas disease; Mycoses; Oropharyngeal candidiasis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 15 Nov 2013 New trial record
    • 13 Sep 2013 Preliminary results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top